The West’s Next Rare Earth Producer — And Possibly Its Biggest

Opinion Piece  ·  Equity Research Australia  ·  Materials
Opinion Piece  ·  17 May 2026
Lindian Resources Limited
ASX:LIN  ·  Materials
The West’s Next Rare Earth Producer — And Possibly Its Biggest

Lindian Resources Limited (ASX:LIN) is months away from joining Lynas and MP Materials as one of only three Western rare earth producers, with first production from its 100%-owned Kangankunde project in Malawi targeted for Q4 2026. With Stage 1 fully funded, a structural US$110/kg NdPr price floor now established through three government-backed offtakes, and the market currently pricing Lindian as a developer rather than a strategic producer, we see material re-rating potential as the company crosses the line into production.

•       100% of a world-class resource. Lindian owns Kangankunde outright: 261Mt at 2.14% TREO with 1.1 million tonnes of contained NdPr, starting at surface with a strip ratio of 0.2:1. A 45-year mine life uses just 62% of the resource, leaving decades of expansion upside.

•       TINA — There Is No Alternative. Only two western rare earth producers exist today (Lynas and  MP Materials) and no other project is anywhere near joining them. Lindian will be next, with first production by end of CY26 and Stage 2 NdPr output of ~12,900tpa surpassing both Lynas (~6,800tpa) and MP Materials (~8,100tpa).

•       Valuation gap is extreme. Lynas and MP Materials trade at 15–17x forward EV/EBITDA, multiples more commonly associated with software companies than miners, because producers of strategic materials are priced as strategic assets. As Lindian crosses the line from developer to producer later this year, we expect a material re-rate towards these levels.

•       Highly sought-after product. Kangankunde’s monazite concentrate contains ~0.07% thorium, roughly 100x below the industry norm, making it one of the most saleable concentrates globally. We expect offtake milestones to be significant re-rating catalysts as they de-risk the project and unlock Stage 2 funding.

•       Low cost operation. Sits in the 1st quartile on the Global Cost Curve

•       Produces a Premium Product. Concentrate Grade is 55% TREO, many Australian peers have projects with below 30% TREO at Concentration stage. Non-radioactive (negligible uranium and thorium)

•       SARECO changes the game. The SARECO plant in Kazakhstan transforms Lindian from a concentrate seller into a downstream MREC producer, lifting payability from ~56% to ~80%. The plant would cost hundreds of millions to replicate and was acquired for US$15m, mostly deferred, with further optionality into rare earth separation.

•       Fully funded and accelerating. Stage 1 (US$40m capex, ~12-month payback) is fully funded with first production Q4 2026, and a fresh A$100m placement brings pro-forma cash to ~A$157m alongside an undrawn US$20m Iluka term loan. Stage 2 funding is largely addressed, and any remaining capital requirement will likely be tied to further offtake.

•       US$110/kg NdPr floor is now structural. Three recent government-backed transactions (MP Materials/DoD, Lynas/JARE, and Lynas/DoW) have all established US$110/kg as the structural Western price floor for NdPr. This underpins all economic analysis in this note, and current market prices have now traded up to this level.

•       Index inclusion catalyst. Recent market cap range of ~A$1.1bn to ~A$1.6bn makes Lindian a prime candidate for S&P/ASX 200 inclusion at the September 2026 rebalance. Smart money will be positioning ahead of the passive buying wave.

Opinion Piece
◆
Contributor perspective
◆
Not a recommendation
◆
No forward estimates or price targets

Member research

Continue reading

Sign in or create a free account to read the complete research report.